Albany Molecular Research, Inc. (NASDAQ:AMRI)

CAPS Rating: 4 out of 5

The Company is a global chemistry-based drug discovery and development company focused on identifying and developing novel biologically active small molecules with applications in the drug market.

Recs

0
Player Avatar cecamado1 (100.00) Submitted: 8/29/2011 3:20:48 PM : Outperform Start Price: $3.53 AMRI Score: -30.50

Langer

Featured Broker Partners


Advertisement